Research and Markets : Sales of Abarelix For the Treatment of Prostate Cancer Was Forecasted to Reach $450 million (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Prostate Cancer - A Therapeutic & Competitive Insight to their offering.

Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine (PR Newswire via Yahoo! Finance)
Merck Serono announced today that patient enrollment has been completed in the CLARITY study, a Phase III pivotal clinical trial evaluating the efficacy and safety of Merck Serono's proprietary oral formulation of cladribine for the treatment of relapsing forms of multiple sclerosis .